Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$593M |
| 2 |
Abbott
ABT
|
+$259M |
| 3 |
AutoZone
AZO
|
+$204M |
| 4 |
AABA
Altaba Inc
AABA
|
+$186M |
| 5 |
D.R. Horton
DHI
|
+$178M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$215M |
| 2 |
Public Service Enterprise Group
PEG
|
+$211M |
| 3 |
Applied Materials
AMAT
|
+$203M |
| 4 |
Intuitive Surgical
ISRG
|
+$194M |
| 5 |
ConocoPhillips
COP
|
+$192M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.49% |
| 2 | Technology | 12.13% |
| 3 | Healthcare | 11.89% |
| 4 | Consumer Discretionary | 11.58% |
| 5 | Industrials | 10.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MLNT
1801
DELISTED
Melinta Therapeutics, Inc. Common Stock
MLNT
| $4.41M | 0.01% |
+55,783
| New | +$4.13M |
|
|
SEE
1802
DELISTED
Sealed Air
SEE
| $4.4M | 0.01% |
89,233
-118,607
| -57% | -$5.45M |
|
|
ALXN
1803
DELISTED
Alexion Pharmaceuticals
ALXN
| $4.39M | 0.01% |
36,694
-227,394
| -86% | -$27.7M |
|
1804
CALL
Ally Financial
ALLY
$12.9B
| $4.37M | 0.01% |
+150,000
| New | +$3.98M |
|
|
LFIN
1805
DELISTED
LongFin Corp Class A Common Stock
LFIN
| $4.36M | 0.01% |
+77,423
| New | +$3.57M |
|
|
WBA
1806
CALL
DELISTED
Walgreens Boots Alliance
WBA
| $4.36M | 0.01% |
+60,000
| New | +$4.23M |
|
1807
uniQure
QURE
$3.53B
| $4.34M | 0.01% |
221,554
-75,014
| -25% | -$1.14M |
|
1808
NetEase
NTES
$79B
| $4.33M | 0.01% |
62,735
-49,450
| -44% | -$3.09M |
|
1809
PUT
Cameco
CCJ
$46.8B
| $4.33M | 0.01% |
469,000
| – | – |
|
|
PDLI
1810
DELISTED
PDL BioPharma, Inc.
PDLI
| $4.32M | 0.01% |
1,577,606
-1,942,992
| -55% | -$5.97M |
|
|
BRFS
1811
DELISTED
BRF SA
BRFS
| $4.31M | 0.01% |
383,133
+297,246
| +346% | +$3.8M |
|
1812
RingCentral
RNG
$5.52B
| $4.29M | 0.01% |
88,530
-268,321
| -75% | -$12.2M |
|
1813
Fresenius Medical Care
FMS
$12.5B
| $4.27M | 0.01% |
81,277
+69,132
| +569% | +$3.43M |
|
|
ACOR
1814
DELISTED
Acorda Therapeutics
ACOR
| $4.26M | 0.01% |
+1,657
| New | +$4.71M |
|
|
TSG
1815
DELISTED
The Stars Group Inc.
TSG
| $4.26M | 0.01% |
182,926
-81,343
| -31% | -$1.77M |
|
|
LKFT
1816
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.91B
| $4.26M | 0.01% |
+45,404
| New | +$4.29M |
|
1817
Belden
BDC
$4.61B
| $4.26M | 0.01% |
55,156
+40,211
| +269% | +$3.32M |
|
1818
LiveRamp
RAMP
$2.29B
| $4.25M | 0.01% |
154,254
+97,104
| +170% | +$2.55M |
|
1819
Smart Sand
SND
$205M
| $4.25M | 0.01% |
490,170
+397,720
| +430% | +$3.08M |
|
|
SHLO
1820
DELISTED
Shiloh Industries Inc
SHLO
| $4.24M | 0.01% |
517,617
-79,517
| -13% | -$723K |
|
|
CAJ
1821
DELISTED
Canon, Inc.
CAJ
| $4.24M | 0.01% |
113,389
-35,277
| -24% | -$1.32M |
|
|
GOGL
1822
DELISTED
Golden Ocean Group
GOGL
| $4.24M | 0.01% |
519,955
+395,265
| +317% | +$3.2M |
|
1823
iShares US Real Estate ETF
IYR
$4.64B
| $4.24M | 0.01% |
+52,268
| New | +$4.24M |
|
1824
Sierra Bancorp
BSRR
$512M
| $4.21M | 0.01% |
158,681
+75,354
| +90% | +$2.02M |
|
|
FPI
1825
Farmland Partners
FPI
$452M
| $4.21M | 0.01% |
+484,537
| New | +$4.34M |
|
Similar funds
Israel Englander's Q4 2017 Portfolio in Review
As of Q4 2017, Israel Englander held 4,357 positions worth $72.5B, up 10% from $65.6B the previous quarter. Its ten largest holdings account for 6.7% of the portfolio.
Israel Englander deployed $3.05B of net new capital in Q4 2017, opening 897 new positions and adding to 1,473 existing holdings. Its largest new stake was Viatris: 2,905,317 shares worth $123M.
By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 14% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Honeywell, an estimated $215M trimmed.
- Israel Englander's largest Q4 2017 buy was Viatris: 2,905,317 shares worth $123M.
- Israel Englander added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $593M increase.
- Israel Englander's biggest Q4 2017 reduction was Honeywell, cutting an estimated $215M.
- Israel Englander fully exited Paychex in Q4 2017, selling an estimated $66.4M.
- Israel Englander's ten largest holdings make up 6.7% of its $72.5B portfolio in Q4 2017.
- Israel Englander opened 897 new positions and closed 601 in Q4 2017.
- Israel Englander's portfolio value rose 10% quarter-over-quarter to $72.5B.
Based on Millennium Management's 13F filing for Q4 2017, filed 14 Feb 2018.